Commentary on "Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series.": COVID-19 disease in patients with recurrent pericarditis during treatment with anakinra.

We read with interest the paper from Navarro-Millan about the use of anakinra in severe COVID-19 patients (1). On the other hand, there is the issue of patients treated with anakinra for their underlying condition and who develop COVID-19 (2).